Back to funds

Vivo Capital, LLC

hedge fundUpdated 9 days ago

Managed by Vivo Capital, Llc • Latest filing Q3 2026

Portfolio value
$908.7M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$1.5B
Q1 2026$1.2B
Q2 2026$1.1B
Q3 2026$908.7M

Top holdings

50 positions as of Q3 2026

View filing
P

Praxis Precision Medicines

Value
$79M
Shares
271.1K
% Port
8.69%
T

Trevi Therapeutics Inc

Value
$60.6M
Shares
4.23M
% Port
6.67%
E

Erasca Inc

Value
$58.9M
Shares
4.02M
% Port
6.49%
A

Arrivent BioPharma Inc

Value
$54.1M
Shares
1.79M
% Port
5.96%
A

Abivax SA

Value
$41.1M
Shares
414.9K
% Port
4.52%
E

Entera Bio Ltd

Value
$35.7M
Shares
12.25M
% Port
3.92%
A

Aclaris Therapeutics Inc

Value
$35.2M
Shares
6.69M
% Port
3.88%
A

Alto Neuroscience Inc

Value
$34.7M
Shares
1.36M
% Port
3.82%
T

Tango Therapeutics Inc

Value
$34.4M
Shares
1.38M
% Port
3.79%
C

Corvus Pharmaceuticals Inc

Value
$32.3M
Shares
2.81M
% Port
3.56%
L

LB Pharmaceuticals Inc

Value
$30.7M
Shares
800.0K
% Port
3.38%
K

Korsana Biosciences Inc

Value
$28.1M
Shares
877.0K
% Port
3.09%
?
13.N/A

Blossomhill Therapeutics Inc

Value
$27.8M
Shares
1.49M
% Port
3.06%
F

Faeth Therapeutics Inc

Value
$25.1M
Shares
844.6K
% Port
2.76%
C

CAMP4 Therapeutics Corporation

Value
$22.6M
Shares
5.58M
% Port
2.48%
A

Achieve Life Science Inc

Value
$22.3M
Shares
2.75M
% Port
2.45%
S

SAB Biotherapeutics Inc

Value
$21.9M
Shares
6.92M
% Port
2.41%
D

DBV Technologies SA

Value
$21.7M
Shares
1.84M
% Port
2.39%
D

Bright Minds Biosciences Inc

Value
$20.8M
Shares
417.9K
% Port
2.29%
D

Design Therapeutics Inc

Value
$20.3M
Shares
1.61M
% Port
2.23%

Explore